HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guoyou Chen Selected Research
Guoyou Chen Research Topics
Disease
9
Neoplasms (Cancer)
06/2022 - 10/2002
4
Breast Neoplasms (Breast Cancer)
01/2021 - 01/2003
2
Atherosclerosis
01/2019 - 01/2018
2
Inflammation (Inflammations)
12/2007 - 07/2006
2
Communicable Diseases (Infectious Diseases)
06/2005 - 03/2004
1
Adenocarcinoma of Lung
06/2022
1
Lung Neoplasms (Lung Cancer)
06/2022
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1
Atopic Dermatitis (Atopic Eczema)
12/2014
1
Autoimmune Diseases (Autoimmune Disease)
11/2007
1
Carcinoma (Carcinomatosis)
06/2005
1
Infections
03/2004
1
Leukemia
02/2003
1
Cardiomyopathies (Cardiomyopathy)
10/2002
1
Hypoglycemia (Reactive Hypoglycemia)
10/2002
1
Sudden Death
10/2002
Drug/Important Bio-Agent (IBA)
3
Antigens
IBA
10/2006 - 03/2004
2
Growth Inhibitors
IBA
01/2021 - 02/2005
2
Resveratrol
IBA
01/2019 - 01/2018
2
Cytokines
IBA
12/2007 - 06/2005
2
Proteins (Proteins, Gene)
FDA Link
06/2005 - 02/2005
2
Messenger RNA (mRNA)
IBA
02/2003 - 10/2002
1
Decitabine
FDA Link
06/2022
1
O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate
IBA
06/2022
1
DNA (Deoxyribonucleic Acid)
IBA
06/2022
1
Glutathione (Reduced Glutathione)
IBA
06/2022
1
Sincalide
FDA Link
06/2022
1
Transferases
IBA
06/2022
1
Long Noncoding RNA
IBA
01/2020
1
Biomarkers (Surrogate Marker)
IBA
01/2018
1
Eicosanoids
IBA
12/2014
1
p38 Mitogen-Activated Protein Kinases
IBA
11/2007
1
Nerve Growth Factor (NGF)
IBA
11/2007
1
NF-kappa B (NF-kB)
IBA
11/2007
1
triptolide
IBA
07/2006
1
growth inhibitory proteins
IBA
02/2005
1
Peptides (Polypeptides)
IBA
03/2004
1
Vaccines
IBA
03/2004
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
03/2004
1
Peroxidase (Myeloperoxidase)
IBA
02/2003
1
GMP Reductase
IBA
02/2003
1
Cadherins (E-Cadherin)
IBA
01/2003
1
Long-Chain Acyl-CoA Dehydrogenase (Long-Chain-Acyl-Coenzyme A Dehydrogenase)
IBA
10/2002
1
Enzymes
IBA
10/2002
Therapy/Procedure
3
Therapeutics
01/2021 - 02/2005